AmSurg (AMSG) Tops Q4 EPS by 4c, Guides FY EPS Above Views

AmSurg (NASDAQ: AMSG) reported Q4 EPS of $1.07, $0.04 better than the analyst estimate of $1.03. Revenue for the quarter came in at $704.3 million versus the consensus estimate of $684.16 million.

GUIDANCE:

AmSurg sees Q1 2016 EPS of $0.77-$0.80, versus the consensus of $0.79.

AmSurg sees FY2016 EPS of $4.26-$4.34, versus the consensus of $4.23. AmSurg sees FY2016 revenue of $3.09-3.13 billion, versus the consensus of $3.05 billion.

For earnings history and earnings-related data on AmSurg (AMSG) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
• Investing.com’s stocks of the week